
    
      This is an observational study in young adult males who received the first dose of the yellow
      fever vaccine when they participated in the Dose response study of the yellow fever vaccine
      produced by Bio Manguinhos Fiocruz. The purpose of this study is to know whether reduced dose
      immunity is maintained for at least ten years. This information is crucial to support the
      recommendation to use fractional dose in adults a topic of great interest to World Health
      Organization.
    
  